TL;DR: Mast cell tumor treatment for dogs depends on the tumor’s grade, stage, and location. Surgery is often the first treatment for localized tumors, while electrochemotherapy, chemotherapy, radiation therapy, and targeted medications may be recommended in more advanced cases.
Hearing “mast cell tumor” is unsettling, but a mast cell tumor in dogs is one of the most common canine cancer diagnoses, and many mast cell tumors are treatable, especially when identified early. Treatment decisions depend on whether the tumor is low-grade or high-grade, localized or metastatic, and whether surgery can achieve clean margins.
Common treatment options include surgery, electrochemotherapy, chemotherapy, radiation therapy, and targeted medications such as toceranib (Palladia). Many low-grade tumors can be managed successfully with surgery alone.
Mast cell tumors account for approximately 16–21% of all canine skin tumors, making them the most common cutaneous tumor diagnosed in dogs.
Families in New Mexico and surrounding states can schedule a consultation with Veterinary Cancer Care for a no-pressure discussion about treatment options.
How Mast Cell Tumor Grade and Stage Shape Treatment Decisions
Key Takeaway: Treatment for a mast cell tumor in a dog depends primarily on histologic grade and clinical stage. Low-grade, localized tumors are often managed with surgery alone, while high-grade or metastatic tumors usually require combined treatment.
Mast cell tumors are the most common cutaneous tumors in dogs, but the disease can behave very differently from one patient to another. Two dogs may receive the same diagnosis but need very different treatment plans depending on how aggressive the tumor cells appear under the microscope and whether the cancer has spread.
“Grade” refers to how abnormal the tumor cells look on pathology. The Patnaik system classifies tumors as Grade I, Grade II, or Grade III. A mast cell tumor grade 2 diagnosis falls in the middle category and can behave unpredictably. The Kiupel system simplifies classification into low-grade or high-grade tumors.
In a peer-reviewed grading study (Sabattini et al., 2015), dogs with Kiupel low-grade tumors had a 94% one-year survival probability, while dogs with high-grade tumors had a 46% one-year survival probability.
“Stage” describes whether the mast cell cancer has spread to nearby lymph nodes or distant organs. Staging often includes lymph node aspirates, bloodwork, abdominal ultrasound, and chest imaging.
Boxers, Labrador Retrievers, Golden Retrievers, Pugs, French Bulldogs, Shar-Peis, and Bull Terriers are among the breeds with documented predisposition to mast cell tumors. Dog mast cell tumor symptoms may include raised skin masses, redness, swelling, itching, or rapidly changing tumor size.
Surgery: The First-Line Treatment for Most Mast Cell Tumors
Surgical removal remains the standard first-line treatment for dogs with localized mast cell disease. For many low-grade tumors that can be completely excised, surgery alone may be the only treatment required. The goal is complete tumor removal with clean margins. Veterinary surgeons typically aim to remove several centimeters of normal tissue surrounding the tumor, along with one fascial plane beneath it. Wider margins reduce the likelihood that microscopic tumor cells remain behind.
After surgery, the pathology report becomes extremely important. “Clean margins” means the pathologist did not identify tumor cells at the edges of the removed tissue. “Incomplete margins” means tumor cells may still remain in the surgical site. Incomplete margins do not automatically mean another major surgery is necessary. The next step depends on the tumor grade, location, and the dog’s overall situation. Families and oncologists may discuss a second surgery, radiation therapy, electrochemotherapy applied to the surgical scar, or close monitoring.
Some treatment plans begin with options other than surgery. Tumors located on the face, in the lower limbs, or near important structures can be difficult to remove completely without compromising function or quality of life. In those cases, electrochemotherapy, radiation, or systemic therapy may play a larger role earlier in the planning process.
Veterinary Cancer Care works closely with families and referring veterinarians to determine which path is realistic, medically appropriate, and aligned with quality-of-life goals, a key focus of this client education guide on canine mast cell tumors.
Electrochemotherapy: A Targeted Option When Surgery Is Not Enough
Key Takeaway: Electrochemotherapy treats mast cell tumors locally by delivering chemotherapy directly into tumor cells alongside electrical pulses. Electrochemotherapy for dogs is most useful for incomplete surgical margins, recurrent tumors, and tumors in locations where wide-margin surgery is not feasible.
Electrochemotherapy for dogs is a localized cancer treatment that combines chemotherapy medication with short electrical pulses delivered directly to the tumor or surgical site. The electrical pulses temporarily increase the permeability of tumor cell membranes, allowing the chemotherapy drug, most commonly bleomycin and cisplatin, to enter cancer cells at dramatically higher concentrations than standard systemic delivery. Because the drug acts locally at the treatment site, systemic side effects are typically minimal.
Electrochemotherapy for dogs is especially useful in situations where surgery alone may not fully control the disease. Veterinary Cancer Care commonly considers electrochemotherapy for incompletely excised mast cell tumors, recurrent tumors, and tumors located in areas where wide-margin surgery is difficult or impossible. Most mast cell tumors are superficial cutaneous or subcutaneous tumors, which makes them particularly well-suited for electrochemotherapy treatment.
During the procedure, the dog is anesthetized or sedated for comfort and safety. The chemotherapy drug may be injected directly into the tumor or administered intravenously, depending on the case. Specialized probes then deliver controlled electrical pulses to the treatment area and surrounding margins. Most patients require a single treatment session, though additional sessions may be recommended for larger or more extensive tumors.
Side effects are generally limited to the treatment site itself. Temporary inflammation, scabbing, swelling, and tissue healing over several weeks are expected local effects. Because the chemotherapy drug remains concentrated at the target area, widespread systemic toxicity is uncommon. Electrochemotherapy is now recognized under international veterinary electrochemotherapy guidelines as an established oncology treatment for superficial tumors in dogs and cats.
Families who want more information about the equipment and approach used at Veterinary Cancer Care can read about the electrochemotherapy machine in our Santa Fe practice and learn more about Dr. Jeannette Kelly’s integrative oncology practice.
Other Treatment Options: Chemotherapy, Radiation, and Targeted Therapy
Some dogs require treatment beyond surgery or electrochemotherapy. High-grade tumors, metastatic disease, and tumors with aggressive biologic behavior often benefit from systemic treatment or referral-based therapies.
Conventional chemotherapy uses medications such as vinblastine, prednisone, and lomustine to help control mast cell tumors in dogs with higher-risk disease. Chemotherapy may be recommended after surgery or alongside other treatments when cancer cells are suspected to have spread beyond the original tumor site.
Veterinary chemotherapy is generally dosed differently from human chemotherapy. Most dogs maintain a good quality of life during treatment, though side effects such as gastrointestinal upset, fatigue, or low white blood cell counts can occur and require monitoring.
Some dogs may also benefit from metronomic chemotherapy, [link once this post is published] which uses lower, continuous doses of chemotherapy medications as part of long-term management.
Radiation therapy is commonly used for incompletely excised tumors or tumors located in areas where surgery cannot safely achieve clean margins. Veterinary Cancer Care coordinates referrals with radiation oncology centers when radiation therapy is appropriate.
Targeted therapy medications, particularly toceranib phosphate (Palladia), are another option for mast cell tumor dog treatment. Toceranib is FDA-approved for canine mast cell tumors and is particularly useful for non-resectable tumors, metastatic disease, or tumors associated with specific c-kit mutations. The medication is given orally and requires ongoing monitoring for gastrointestinal, liver, and kidney side effects.
Building an Integrative Treatment Plan for Your Dog
Key Takeaway: Most successful mast cell tumor treatment for dogs involves a combination of therapies tailored to the dog, the tumor, and the family’s goals for care.
Treatment decisions are rarely as simple as choosing one procedure. Many dogs benefit from a multimodal approach, such as surgery followed by electrochemotherapy on the surgical scar, or surgery combined with chemotherapy for high-grade disease.
Our integrative oncology approach looks beyond the tumor itself. Diet, supplementation, pain management, stress reduction, mobility, and the dog’s overall quality of life all influence treatment planning. Veterinary Cancer Care also coordinates closely with primary-care veterinarians so ongoing care can continue close to home whenever possible.
Families often arrive with different goals. Some pursue aggressive curative-intent treatment, while others prioritize comfort, symptom management, and time together. Both approaches are valid. A board-certified veterinary oncologist can help families understand the medical options without pressure to commit immediately.
The first consultation at Veterinary Cancer Care is a conversation, not an obligation. Referrals are not required, and many families travel to Santa Fe from across New Mexico for an initial oncology evaluation before continuing portions of care with their local veterinarian.
Families interested in Veterinary Cancer Care’s diagnostic and treatment services, or in personalized treatment guidance, can learn more on the linked pages.
Frequently Asked Questions
What is the best treatment for mast cell tumors in dogs?
There is no single “best” treatment for mast cell tumors in dogs because treatment depends on the tumor’s grade, stage, and location. For many localized low-grade tumors, surgery alone is highly effective. If surgical margins are incomplete or the tumor is located in a difficult area, electrochemotherapy or radiation therapy may be added to improve local control. High-grade or metastatic tumors often require a combination of surgery, chemotherapy, and targeted therapy. A board-certified veterinary oncologist can recommend the most appropriate plan after reviewing pathology, staging results, and the dog’s overall health. Families can talk with our team to discuss treatment recommendations.
How long can a dog live with a mast cell tumor?
Mast cell tumor dog life expectancy varies widely depending on the tumor’s grade and stage. In a peer-reviewed grading study (Sabattini et al., 2015), dogs with Kiupel low-grade mast cell tumors had a 94% one-year survival probability, while dogs with high-grade tumors had a 46% one-year survival probability. Many dogs with low-grade tumors that are completely removed with clean surgical margins live out their normal lifespan without recurrence. High-grade tumors are more aggressive and often require long-term management. Survival statistics describe groups of dogs rather than predicting outcomes for an individual patient.
Can a dog be cured of a mast cell tumor?
Many low-grade mast cell tumors that are completely excised with clean margins are functionally cured, meaning the tumor never returns during the dog’s lifetime. High-grade tumors and tumors that have spread to lymph nodes or distant organs are typically managed long-term rather than cured outright, though some dogs achieve durable remission with combined treatment. Oncology specialists use the word “cure” carefully because cancer can occasionally recur years later. Complete excision of a low-grade tumor remains one of the strongest predictors of long-term control.
What shrinks mast cell tumors in dogs?
Targeted cancer treatment is what shrinks mast cell tumors most reliably. Surgery physically removes accessible tumors. Electrochemotherapy reduces tumor size locally by delivering chemotherapy directly into cancer cells with electrical pulses. Radiation therapy and systemic chemotherapy can also reduce tumor burden in specific cases. Prednisone and other steroids may temporarily shrink or reduce inflammation around a mast cell tumor, but steroids do not eliminate the underlying cancer and can complicate later biopsy interpretation. Steroids should only be used under veterinary guidance.
What is electrochemotherapy and why is it used for mast cell tumors?
Electrochemotherapy uses short electrical pulses to temporarily open tumor cell membranes, allowing chemotherapy drugs such as bleomycin to enter cancer cells at much higher concentrations. Side effects are usually minimal because the medication acts locally. Electrochemotherapy is especially useful for incompletely excised tumors, recurrent tumors, or tumors in locations where surgery cannot safely achieve clean margins. Families can learn more about the electrochemotherapy machine in our Santa Fe practice.
How much does mast cell tumor treatment for dogs cost?
The cost of mast cell tumor treatment for dogs depends on the type of treatment and whether multiple therapies are required. Surgical removal of a small localized tumor is generally the least expensive option. Electrochemotherapy adds procedural costs when used after surgery or for recurrent tumors. Multi-modal treatment plans involving chemotherapy or radiation therapy typically cost more. Families in Santa Fe and New Mexico can contact Veterinary Cancer Care directly for individualized estimates and information about available payment options.
Working with Our Santa Fe Oncology Team
Veterinary Cancer Care provides integrative oncology support for families facing a mast cell tumor diagnosis in dogs. Families often seek out Veterinary Cancer Care because the practice combines board-certified oncology expertise, individualized treatment planning, and in-house electrochemotherapy in a supportive, no-pressure setting.
Families with a recent diagnosis or dogs with suspicious lumps that still need biopsy evaluation can schedule a consultation directly with Veterinary Cancer Care. Referrals are not required, and Veterinary Cancer Care coordinates ongoing treatment with primary-care veterinarians throughout New Mexico and surrounding states.
Call 505-982-4492 to speak with the Santa Fe oncology team.